Download

Download Full Text (337 KB)

Contents

  • Breast Cancer Treatment without Surgery: New approach may let certain breast cancer patients who respond to systemic therapy forgo surgery
  • INBRIEF: Targeted Drug BLU-667 Shows Promise against Solid Tumors with RET Alterations
  • Diet May Improve Gut Microbiome in Colorectal Cancer Survivors: Trial tests whether adding beans to diet affects markers of cancer risk, metabolic health
  • TRK Inhibition Shows Activity in Solid Tumors: Early results of clinical trials for adult, pediatric patients with NTRK gene fusions show promise
  • HOUSE CALL: Preparing for Natural Disasters-People with cancer or other chronic illnesses should take extra precautions

Publication Date

5-1-2018

Publisher

The University of Texas MD Anderson Cancer Center

City

Houston, Texas

Keywords

Centers for Disease Control and Prevention (U.S.); Kuerer, Henry M. (Henry Mark); Subbiah, Vivek; Hu, Mimi; Daniel-MacDougall, Carrie; Hong, David S.; Berkheiser, Matthew; Vilar-Sanchez, Eduardo; Breast Neoplasms; Neoadjuvant Therapy; Genes, erbB-2; Clinical Trials as Topic; pralsetinib; Antineoplastic Agents; Receptor Protein-Tyrosine Kinases; Thyroid Neoplasms; Colorectal Neoplasms; Cancer Survivors; Diet; Gastrointestinal Microbiome; Dietary Fiber; Oncogene Proteins; larotrectinib; Glioblastoma; Lung Neoplasms; Aza Compounds; Natural Disasters; Colorectal Neoplasms, Hereditary Nonpolyposis; Polyps; Adenomatous Polyposis Coli; DNA Mismatch Repair.

Disciplines

History of Science, Technology, and Medicine | Oncology

Conditions Governing Access

Redacted

OncoLog, Volume 63, Number 05-06, May - June 2018

Share

COinS